Hashida M - Search Results

1

A physiological role of interferon (IFN)-beta derived from tumor: tumor growth of a mouse bladder carcinoma line MBT-2 is partially suppressed by autocrine IFN-beta.

Kawabata K, Okamoto S, Takakura Y, Hashida M, Hashimura T, Watanabe Y. Kawabata K, et al. Among authors: hashida m. Cancer Lett. 1997 Feb 26;113(1-2):159-64. doi: 10.1016/s0304-3835(96)04594-6. Cancer Lett. 1997. PMID: 9065816

2

Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.

Sakurai F, Terada T, Maruyama M, Watanabe Y, Yamashita F, Takakura Y, Hashida M. Sakurai F, et al. Among authors: hashida m. Cancer Gene Ther. 2003 Sep;10(9):661-8. doi: 10.1038/sj.cgt.7700617. Cancer Gene Ther. 2003. PMID: 12944985

3

Non-polarized secretion of mouse interferon-beta from gene-transferred human intestinal Caco-2 cells.

Kawabata K, Kondo M, Watanabe Y, Takakura Y, Hashida M. Kawabata K, et al. Among authors: hashida m. Pharm Res. 1997 Apr;14(4):483-5. doi: 10.1023/a:1012151616910. Pharm Res. 1997. PMID: 9144735

4

Secretion polarity of interferon-beta in epithelial cell lines.

Nakanishi K, Watanabe Y, Maruyama M, Yamashita F, Takakura Y, Hashida M. Nakanishi K, et al. Among authors: hashida m. Arch Biochem Biophys. 2002 Jun 15;402(2):201-7. doi: 10.1016/S0003-9861(02)00093-0. Arch Biochem Biophys. 2002. PMID: 12051664

5

Expression and visualization of a human interferon-beta-enhanced green fluorescent protein chimeric molecule in cultured cells.

Nakamura M, Maruyama M, Yamashita F, Takakura Y, Hashida M, Watanabe Y. Nakamura M, et al. Among authors: hashida m. Biol Pharm Bull. 2004 Mar;27(3):411-4. doi: 10.1248/bpb.27.411. Biol Pharm Bull. 2004. PMID: 14993812 Free article.

6

Exogenous expression of interferon-beta in cultured brain microvessel endothelial cells.

Nakamura M, Yamaguchi S, Watanabe Y, Yamashita F, Takakura Y, Hashida M. Nakamura M, et al. Among authors: hashida m. Biol Pharm Bull. 2004 Sep;27(9):1441-3. doi: 10.1248/bpb.27.1441. Biol Pharm Bull. 2004. PMID: 15340234 Free article.

7

[Control of in vivo characteristics of gene and antisense DNA disposition].

Takakura Y, Miyao T, Kawabata K, Hashida M. Takakura Y, et al. Among authors: hashida m. Gan To Kagaku Ryoho. 1994 Feb;21(3):320-4. Gan To Kagaku Ryoho. 1994. PMID: 7509150 Japanese.

8

The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.

Kawabata K, Takakura Y, Hashida M. Kawabata K, et al. Among authors: hashida m. Pharm Res. 1995 Jun;12(6):825-30. doi: 10.1023/a:1016248701505. Pharm Res. 1995. PMID: 7667185

9

Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.

Takakura Y, Hashida M. Takakura Y, et al. Among authors: hashida m. Crit Rev Oncol Hematol. 1995 Mar;18(3):207-31. doi: 10.1016/1040-8428(94)00131-c. Crit Rev Oncol Hematol. 1995. PMID: 7695833 Review. No abstract available.

10

Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.

Mahato RI, Kawabata K, Nomura T, Takakura Y, Hashida M. Mahato RI, et al. Among authors: hashida m. J Pharm Sci. 1995 Nov;84(11):1267-71. doi: 10.1002/jps.2600841102. J Pharm Sci. 1995. PMID: 8587040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters